Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-09-18
2007-09-18
Anderson, Rebecca (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S336100
Reexamination Certificate
active
10965155
ABSTRACT:
The invention relates to a group of 1H-imidazole derivatives which are modulators of cannabinoid receptors, to methods for the preparation of these compounds, to novel intermediates useful for the synthesis of said imidazole derivatives, to methods for the preparation of these intermediates, to pharmaceutical compositions containing one or more of these 1H-imidazole derivatives as active ingredient, as well as to the use of these pharmaceutical compositions for the treatment of psychiatric and neurological disorders in which cannabinoid receptors are involved.The compounds have the general formula (I)wherein R, R1-R4and X have the meanings given in the specification.
REFERENCES:
patent: 2004/0214855 (2004-10-01), Carpino et al.
patent: 2005/0026983 (2005-02-01), Carpino
Keizer Hiskias G.
Kruse Cornelis G.
Lange Josephus H. M.
Van Stuivenberg Herman H.
Anderson Rebecca
Barker Michael P.
Finnegan Henderson Farabow Garrett & Dunner L.L.P.
Solvay Pharmaceuticals, Inc.
LandOfFree
1H-imidazole derivatives as cannabinoid receptor modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1H-imidazole derivatives as cannabinoid receptor modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1H-imidazole derivatives as cannabinoid receptor modulators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3761773